Devin W. Steenkamp, MBChB

Assistant Professor, Medicine

Devin Steenkamp
75 E. Newton St

Biography

Devin Steenkamp is an endocrinologist with a particular interest in type 1 diabetes and atypical diabetes phenotypes such as monogenic diabetes. He is the Director of the Clinical Diabetes Program in the Section of Endocrinology, Diabetes and Nutrition at Boston Medical Center/Chobanian and Avedisian School of Medicine and his clinical practice and research interests are focused on the application of diabetes technologies in care

Other Positions

  • Member, Evans Center for Interdisciplinary Biomedical Research, Boston University

Education

  • University of Pretoria, MBChB

Publications

  • Published on 8/24/2023

    Steenkamp DW, Fantasia KL, Wolpert HA. Optimizing Glycemic Outcomes for Minoritized and Medically Underserved Adults Living with Type 1 Diabetes. Endocrinol Metab Clin North Am. 2024 Mar; 53(1):67-80. PMID: 38272599.

    Read at: PubMed
  • Published on 8/3/2023

    Ferkowicz MJ, Verma A, Barwinska D, Ferreira RM, Henderson JM, Kirkpatrick M, Silva PS, Steenkamp DW, Phillips CL, Waikar SS, Sutton TA. Molecular Signatures of Glomerular Neovascularization in a Patient with Diabetic Kidney Disease. Clin J Am Soc Nephrol. 2023 Aug 03; 19(2):266-75. PMID: 37533147.

    Read at: PubMed
  • Published on 3/6/2023

    Steenkamp DW, Cheney MC, Ju Z, Rodbard D, Wolpert HA. Proof-of-concept Application of Continuous Glucose Monitoring Data Analytics to Identify Diabetes Glucotypes. J Endocr Soc. 2023 Mar 06; 7(5):bvad038. PMID: 37035501.

    Read at: PubMed
  • Published on 12/19/2022

    Williams ME, Steenkamp D, Wolpert H. Making sense of glucose sensors in end-stage kidney disease: A review. Front Clin Diabetes Healthc. 2022; 3:1025328. PMID: 36992784.

    Read at: PubMed
  • Published on 10/21/2022

    Steenkamp DW, Piarulli A, Middelbeek RJW, Wolpert HA. Severe hypoglycaemia while using a hybrid closed-loop insulin pump system: A reminder of the continued importance of patient education for pre-emptive hypoglycaemia mitigation. Diabet Med. 2023 Mar; 40(3):e14975. PMID: 36251520.

    Read at: PubMed
  • Published on 10/19/2022

    Marks BE, Mungmode A, Neyman A, Levin L, Rioles N, Eng D, Lee JM, Basina M, Hawah-Jones N, Mann E, O'Malley G, Wilkes M, Steenkamp D, Aleppo G, Accacha S, Ebekozien O. Baseline Quality Improvement Capacity of 33 Endocrinology Centers Participating in the T1D Exchange Quality Improvement Collaborative. Clin Diabetes. 2022; 41(1):35-44. PMID: 36714248.

    Read at: PubMed
  • Published on 8/15/2022

    Ebekozien O, Mungmode A, Buckingham D, Greenfield M, Talib R, Steenkamp D, Haw JS, Odugbesan O, Harris M, Mathias P, Dickinson JK, Agarwal S. Achieving Equity in Diabetes Research: Borrowing From the Field of Quality Improvement Using a Practical Framework and Improvement Tools. Diabetes Spectr. 2022; 35(3):304-312. PMID: 36072814.

    Read at: PubMed
  • Published on 2/16/2022

    Modzelewski KL, Murati J, Charoenngam N, Rehm C, Steenkamp DW. Delays in Continuous Glucose Monitoring Device Initiation: A Single Center Experience and a Call to Change. Diabetes Technol Ther. 2022 Jun; 24(6):390-395. PMID: 35099277.

    Read at: PubMed
  • Published on 2/9/2022

    Fantasia KL, Demers LB, Steenkamp DW, Modzelewski KL. An Opportunity for Improvement: Evaluation of Diabetes Technology Education Among Adult Endocrinology Training Programs. J Diabetes Sci Technol. 2023 Sep; 17(5):1274-1283. PMID: 35135342.

    Read at: PubMed
  • Published on 10/22/2021

    Ju Z, Piarulli A, Bielick L, Marschall S, Brouillard E, Steenkamp D. Advanced Diabetes Technology Remains Underutilized in Underserved Populations: Early Hybrid Closed-Loop System Experience at an Academic Safety Net Hospital. Diabetes Technol Ther. 2022 02; 24(2):143-147. PMID: 34569850.

    Read at: PubMed

View 39 more publications: View full profile at BUMC

View all profiles